| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,205 | 20,878 | 18,002 | 23,377 | | Cost of Revenue | 5,160 | 5,411 | 6,202 | 7,087 | | | Gross Profit | 10,045 | 15,467 | 11,800 | 16,290 | | | Operating Expenses | | Research Development | 4,458 | 4,438 | 4,843 | 5,259 | | Selling General and Administrative | 9,175 | 9,297 | 9,425 | 12,182 | | Non Recurring |
-
|
-
|
-
| 784 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,588) | 1,732 | (2,468) | (1,935) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 162 | (644) | 34 | 977 | | Earnings Before Interest And Taxes | (3,426) | 1,088 | (2,434) | (958) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,426) | 1,088 | (2,434) | (958) | | Income Tax Expense | 1,111 | 1,111 | 1,101 | 1,711 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,537) | (23) | (3,535) | (2,669) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,537) | (23) | (3,535) | (2,669) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,537) | ($23) | ($3,535) | ($2,669) |
|
0.51% Nasdaq 
0.03 (1.02%) 
Income Statement
